Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

NCT02800642 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Retinal Vein Occlusion

Interventions

DRUG: Aflibercept (Eylea, BAY86-5321)

Sponsor

Bayer